The proposed bill would update current statutes to allow for the prescription of 3,4-methylenedioxymethamphetamine (MDMA) for firefighters and certified peace officers diagnosed with PTSD, contingent upon FDA approval and rescheduling of MDMA. It would insert provisions requiring employers to provide workers' compensation coverage for one complete course of MDMA treatment as prescribed by a psychiatrist, following an independent medical examination. Additionally, the bill mandates the Industrial Commission of Arizona to report annually on the costs associated with MDMA treatment, with these provisions taking effect only if MDMA is approved for PTSD treatment by January 1, 2029.

Moreover, the bill appropriates $10 million from the state General Fund for FY 2027 to the Department of Health Services for grants related to clinical trials and research on MDMA as a PTSD treatment. It specifies eligibility criteria for grant recipients, including public institutions of higher education and clinical trial sponsors, and ensures that the appropriation will not lapse. Definitions for relevant terms are also included to clarify eligibility for coverage and to conform existing statutes to the new provisions regarding MDMA treatment.

Statutes affected:
Introduced Version: 23-973, 36-2511, 36-2517.03, 38-842, 36-2512, 36-2513, 36-2514, 36-2515, 36-2516, 36-2517, 36-2517.02